Ordering human CD34+CD10-CD19+ pre/pro-B-cell and CD19- common lymphoid progenitor stages in two pro-B-cell...

Area of Science:

• Immunology and Hematopoiesis
• Cell Biology
• Molecular Biology

Background:

• The precise origins and developmental pathways of human B-cells remain incompletely understood.
• Distinguishing between distinct precursor populations and their contribution to B-cell development is crucial.
• Previous studies in mice suggest lineage divergence in B-cell development, with implications for leukemia origins.

Purpose of the Study:

• To investigate whether human "pre/pro-B" and "common lymphoid progenitor (CLP)/early-B" cells are alternate precursors to "pro-B" cells.
• To determine if pro-B cells derived from these progenitors follow the same or distinct developmental pathways.
• To explore the implications of these pathways for human B-lineage leukemias.

Main Methods:

• Flow cytometry for cell sorting and characterization of progenitor populations.
• Gene expression profiling to analyze cellular identity and differentiation.
• Immunoglobulin heavy chain V(H)-D-J(H) gene sequencing to track B-cell receptor diversification.
• Co-culture of sorted cord blood progenitors with bone marrow stromal cells (S17).

Main Results:

• Multipotent progenitors generate an initial wave of "unilineage" pre/pro-B cells (Pax5(+)TdT(-)) followed by "multilineage" CLP/early-B cells.
• These successive progenitor waves give rise to distinct pro-B cells through two independent, layered developmental pathways.
• A divergence in human B-cell development pathways is observed, analogous to mouse B-cell lineages, with implications for infant B-lineage leukemias.

Conclusions:

• Human B-cell development involves at least two distinct layered pathways originating from multipotent progenitors.
• The Pax5(+)TdT(-) pre/pro-B pathway is distinct from the early-B pathway, with differing implications for leukemia development.
• These findings provide critical insights into early human B-cell differentiation and its potential links to hematological malignancies.